Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Big data analysis applied to intermittent androgen deprivation therapy for prostate cancer patients
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: CORDERO, José Antonio (Blanquerna/University Ramon Llull, Pharmacokinetics, Barcelona, Spain)
- Co-author(s): José Antonio Cordero: Blanquerna School of Health Science, University Ramon Llull, Barcelona, Spain
Xavier Bonfill: CIBERESP, Iberoamerican Cochrane Centre, Barcelona, Spain;Sant Pau Biomedical Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
BackgroundsHerewith, you can see one application of big data that can be expanded to many other areas where electronic prescription is available. Intermittent androgen deprivation (IAD) is an adequate evidence-based alternative for substituting at least temporarily continuous androgen deprivation (CAD) in the treatment of prostate cancer patients.
A.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019